FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037066782> ?p ?o ?g. }

• W2037066782 endingPage "284" @default.
• W2037066782 startingPage "284" @default.
• W2037066782 abstract "Purpose : Theophylline has recently been reported to have concurrent anti-inflammatory effects at low therapeutic plasma concentrations which are below the doses at which significants, clinically useful bronchodilatation is evident. Sustained-release formulation in capsule and dry syrup forms were developed to reduce its adverse effects and improve its clinical effects. We compared the therapeutic effects of theophylline dry syrup and capsules in children with mild asthma. Methods : Ninety children with mild asthma were randomized to receive either theophylline dry syrup (n=44) or theophylline capsules (n=46); 4 mg per kilogram of body weight, twice a day, for 12 weeks. Baseline and serial measurements of daytime and nighttime asthma symptom score were performed. Compliance scores, drug swallowing scores, and drug usability scores were measured every 4 weeks. Each scoring was rated on a scale of 0-4. Serum theophylline concentration were measured at 4 and at 12 weeks. To examine the anti-inflammatory effect of theophylline on asthma, Serum eosinophilic cationic protein as a marker of airway inflammation caused by eosinophil was measured 12 weeks pre- and post-administration. Results : The daytime and nighttime asthma symptom scores of the two groups after 4 weeks significantly improved over the baseline score. Daytime and nighttime asthma symptom scores in the dry syrup group were statistically lower at all time points except for the nighttime symptom scores at 4 weeks. Compliance scores, drug swallowing scores, and drug usability scores in the dry syrup group were significantly higher at the end time point. Only in the dry syrup group was the serum ECP at the end time point statistically lower than baseline. Conclusion : Low-dose sustained-release theophylline may be safe and effective in bronchial asthma and this effect may be mediated by its anti-inflammatory action mechanisms. Especially, when used in children with asthma, dry syrup formulation is recommended because of its higher compliance than capsule formulation." @default.
• W2037066782 created "2016-06-24" @default.
• W2037066782 creator A5000352521 @default.
• W2037066782 creator A5011861620 @default.
• W2037066782 creator A5013690215 @default.
• W2037066782 creator A5016437223 @default.
• W2037066782 creator A5025883687 @default.
• W2037066782 creator A5030369856 @default.
• W2037066782 creator A5030704500 @default.
• W2037066782 creator A5043847161 @default.
• W2037066782 creator A5070917498 @default.
• W2037066782 date "2007-01-01" @default.
• W2037066782 modified "2023-10-16" @default.
• W2037066782 title "Therapeutic comparison between low-dose sustained-release theophylline dry syrup and capsule in children with mild persistent asthma" @default.
• W2037066782 cites W1969448591 @default.
• W2037066782 cites W1984566761 @default.
• W2037066782 cites W1985063313 @default.
• W2037066782 cites W1989796481 @default.
• W2037066782 cites W1992091782 @default.
• W2037066782 cites W2000501628 @default.
• W2037066782 cites W2007568364 @default.
• W2037066782 cites W2013407710 @default.
• W2037066782 cites W2014133471 @default.
• W2037066782 cites W2025058125 @default.
• W2037066782 cites W2061443352 @default.
• W2037066782 cites W2073174532 @default.
• W2037066782 cites W2075125763 @default.
• W2037066782 cites W2078018113 @default.
• W2037066782 cites W2079041573 @default.
• W2037066782 cites W2083425324 @default.
• W2037066782 cites W2087509980 @default.
• W2037066782 cites W2095582100 @default.
• W2037066782 cites W2099722677 @default.
• W2037066782 cites W2110694086 @default.
• W2037066782 cites W2113562144 @default.
• W2037066782 cites W2125225833 @default.
• W2037066782 cites W2141144196 @default.
• W2037066782 cites W2144266634 @default.
• W2037066782 cites W2153010996 @default.
• W2037066782 cites W2164147349 @default.
• W2037066782 cites W2166084959 @default.
• W2037066782 cites W2168958757 @default.
• W2037066782 cites W2171188505 @default.
• W2037066782 cites W3140217998 @default.
• W2037066782 cites W4233036449 @default.
• W2037066782 doi "https://doi.org/10.3345/kjp.2007.50.3.284" @default.
• W2037066782 hasPublicationYear "2007" @default.
• W2037066782 type Work @default.
• W2037066782 sameAs 2037066782 @default.
• W2037066782 citedByCount "1" @default.
• W2037066782 countsByYear W20370667822018 @default.
• W2037066782 crossrefType "journal-article" @default.
• W2037066782 hasAuthorship W2037066782A5000352521 @default.
• W2037066782 hasAuthorship W2037066782A5011861620 @default.
• W2037066782 hasAuthorship W2037066782A5013690215 @default.
• W2037066782 hasAuthorship W2037066782A5016437223 @default.
• W2037066782 hasAuthorship W2037066782A5025883687 @default.
• W2037066782 hasAuthorship W2037066782A5030369856 @default.
• W2037066782 hasAuthorship W2037066782A5030704500 @default.
• W2037066782 hasAuthorship W2037066782A5043847161 @default.
• W2037066782 hasAuthorship W2037066782A5070917498 @default.
• W2037066782 hasBestOaLocation W20370667821 @default.
• W2037066782 hasConcept C126322002 @default.
• W2037066782 hasConcept C19831878 @default.
• W2037066782 hasConcept C2776042228 @default.
• W2037066782 hasConcept C2778095195 @default.
• W2037066782 hasConcept C2778778583 @default.
• W2037066782 hasConcept C2780035454 @default.
• W2037066782 hasConcept C42219234 @default.
• W2037066782 hasConcept C59822182 @default.
• W2037066782 hasConcept C71924100 @default.
• W2037066782 hasConcept C86803240 @default.
• W2037066782 hasConcept C98274493 @default.
• W2037066782 hasConceptScore W2037066782C126322002 @default.
• W2037066782 hasConceptScore W2037066782C19831878 @default.
• W2037066782 hasConceptScore W2037066782C2776042228 @default.
• W2037066782 hasConceptScore W2037066782C2778095195 @default.
• W2037066782 hasConceptScore W2037066782C2778778583 @default.
• W2037066782 hasConceptScore W2037066782C2780035454 @default.
• W2037066782 hasConceptScore W2037066782C42219234 @default.
• W2037066782 hasConceptScore W2037066782C59822182 @default.
• W2037066782 hasConceptScore W2037066782C71924100 @default.
• W2037066782 hasConceptScore W2037066782C86803240 @default.
• W2037066782 hasConceptScore W2037066782C98274493 @default.
• W2037066782 hasIssue "3" @default.
• W2037066782 hasLocation W20370667821 @default.
• W2037066782 hasOpenAccess W2037066782 @default.
• W2037066782 hasPrimaryLocation W20370667821 @default.
• W2037066782 hasRelatedWork W1990972687 @default.
• W2037066782 hasRelatedWork W1999149272 @default.
• W2037066782 hasRelatedWork W2019391076 @default.
• W2037066782 hasRelatedWork W2055905370 @default.
• W2037066782 hasRelatedWork W2094555163 @default.
• W2037066782 hasRelatedWork W2164754849 @default.
• W2037066782 hasRelatedWork W2395505978 @default.
• W2037066782 hasRelatedWork W2414756918 @default.
• W2037066782 hasRelatedWork W2470457987 @default.
• W2037066782 hasRelatedWork W1753320907 @default.

• next